索引超出了数组界限。 文章摘要
|本期目录/Table of Contents|

[1]张茸祯.大黄素在心血管疾病中的应用[J].国际心血管病杂志,2023,02:92-94.
点击复制

大黄素在心血管疾病中的应用(PDF)

《国际心血管病杂志》[ISSN:1006-6977/CN:61-1281/TN]

期数:
2023年02期
页码:
92-94
栏目:
综述
出版日期:
2023-03-20

文章信息/Info

Title:
-
作者:
张茸祯
150007 哈尔滨医科大学附属第一医院心血管内科
Author(s):
-
关键词:
大黄素; 蒽醌类; 心血管疾病
Keywords:
-
分类号:
-
DOI:
10.3969/j.issn.1673-6583.2023.02.008
文献标识码:
-
摘要:
大黄素是从草本植物中分离出来的天然蒽醌类衍生物，其活性成分具有利尿、 松弛血管、抗菌、抗病毒、抗炎及抗癌等多种作用。多项研究证明大黄素在心血管疾病中 具有调控作用，包括动脉粥样硬化、心肌缺血再灌注损伤、心肌肥厚及心肌纤维化等。
Abstract:
-

参考文献/References

[1] Cui Y, Chen LJ, Huang T, et al. The pharmacology, toxicology and therapeutic potential of anthraquinone derivative emodin[J]. Chin J Nat Med, 2020, 18(6):425-435.
[2] Li QQ, Gao J, Pang XH, et al. Molecular mechanisms of action of emodin: as an anti-cardiovascular disease drug[J]. Front Pharmacol, 2020, 11:559607.
[3] Luo N, Fang J, Wei LQ, et al. Emodin in atherosclerosis prevention: pharmacological actions and therapeutic potential[J]. Eur J Pharmacol, 2021, 890:173617.
[4] Pang XM, Liu JT, Li YX, et al. Emodin inhibits homocysteineinduced C-reactive protein generation in vascular smooth muscle cells by regulating PPARγ expression and ROS-ERK1/2/p38 signal pathway[J]. PLoS One, 2015, 10(7): e0131295.
[5] 白岩, 苏振丽, 孙瀚麒, 等. 芦荟大黄素对高脂血症大鼠心肌 炎作用的研究[J]. 哈尔滨医科大学学报, 2018, 52(1):11-14.
[6] 王立民, 刘有旺, 王恩波, 等. 以大黄素为声敏剂介导声动 力疗法对小鼠动脉粥样硬化治疗作用的研究[J]. 医学信息, 2018, 31(6):58-60．
[7] Shou XL, Zhou RF, Zhu LY, et al. Emodin, a Chinese herbal medicine, inhibits reoxygenation-induced injury in cultured human aortic endothelial cells by regulating the peroxisome Proliferator-Activated receptor-γ (PPAR-γ) and endothelial nitric oxide synthase (eNOS) signaling pathway[J]. Med Sci Monit, 2018, 24:643-651.
[8] Ye BZ, Chen XD, Dai SS, et al. Emodin alleviates myocardial ischemia/reperfusion injury by inhibiting gasdermin D-mediated pyroptosis in cardiomyocytes[J]. Drug Des Devel Ther, 2019, 13:975-990.
[9] Zhang XZ, Qin QJ, Dai HY, et al. Emodin protects H9c2 cells from hypoxia-induced injury by up-regulating miR-138 expression[J]. Braz J Med Biol Res, 2019, 52(3):e7994.
[10] Li Y, Xu QQ, Shan CS, et al. Combined use of emodin and ginsenoside Rb1 exerts synergistic neuroprotection in cerebral ischemia/reperfusion rats[J]. Front Pharmacol, 2018, 9:943.
[11] Wang YQ, Liu Q, Cai JY, et al. Emodin prevents renal ischemia-reperfusion injury via suppression of CAMKII/ DRP1-mediated mitochondrial fission[J]. Eur J Pharmacol, 2022, 916:174603.
[12] 祁蕾, 苑博, 傅强. 缺氧/再复氧与脂多糖激活肠上皮细胞核 转录因子-κB和低氧诱导因子-1α信号通路以及大黄素对其 的干预作用[J]. 中华危重病急救医学, 2014, 26(6):409-414.
[13] Evans LW, Bender A, Burnett L, et al. Emodin and emodinrich rhubarb inhibits histone deacetylase (HDAC) activity and cardiac myocyte hypertrophy[J]. J Nutr Biochem, 2020, 79:108339.
[14] Evans L, Shen Y, Bender A, et al. Divergent and overlapping roles for selected phytochemicals in the regulation of pathological cardiac hypertrophy[J]. Molecules, 2021, 26(5): 1210.
[15] Gao J, Zhang KL, Wang Y, et al. A machine learning-driven study indicates emodin improves cardiac hypertrophy by modulation of mitochondrial SIRT3 signaling[J]. Pharmacol Res, 2020, 155:104739.
[16] Guan RJ, Wang X, Zhao XM, et al. Emodin ameliorates bleomycin-induced pulmonary fibrosis in rats by suppressing epithelial-mesenchymal transition and fibroblast activation[J]. Sci Rep, 2016, 6:35696.
[17] Xiao D, Zhang Y, Wang R, et al. Emodin alleviates cardiac fibrosis by suppressing activation of cardiac fibroblasts via upregulating metastasis associated protein 3[J]. Acta Pharm Sin B, 2019, 9(4):724-733.
[18] Zhang HM, Wang FP, Qiu Y, et al. Emodin inhibits coxsackievirus B3 replication via multiple signalling cascades leading to suppression of translation[J]. Biochem J, 2016, 473(4):473-485.
[19] 吴常裕, 杨海燕. 大黄素对病毒性心肌炎患者的疗效及血清 指标的影响[J]. 临床药物治疗杂志, 2018, 16(9):39-42．
[20] Li HM, Liu X, Meng ZY, et al. Kanglexin delays heart aging by promoting mitophagy[J]. Acta Pharmacol Sin, 2022, 43(3): 613-623.

备注/Memo

备注/Memo:
通信作者：张茸祯， E-mail：524684382@qq.com
更新日期/Last Update: 2023-03-20